ArticleFrontiers in oncology2026

Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center.

Isabella Schwörer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.